Discussant review - STEP-HFpEF Programme

13 May 2024 (14:05 - 14:09)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Assistant Professor Dimitrios T Farmakis

National & Kapodistrian University of Athens, Athens (Greece)

9 More presentations in this session

Presentation thumbnail

Outcomes with aspirin avoidance after implantation of a Fully Magnetically Levitated LVAD in patients with coronary, cerebral or peripheral vascular disease: the ARIES HM3 randomized clinical trial

Professor F. Gustafsson (Pleasanton, US)

Presentation thumbnail

Discussant review - ARIES

Doctor O. Dar (London, GB)

Presentation thumbnail

Semaglutide therapy and diuretic use in obesity-related HFpEF: insights from the STEP-HFpEF programme

Professor S. Verma (Toronto, CA)

Presentation thumbnail

Aficamten for the treatment of symptomatic obstructive hypertrophic cardiomyopathy: SEQUOIA-HCM an international multicenter phase 3 trial

Doctor M. Maron (Burlington, US)

Presentation thumbnail

Discussant review - Quantitative Understanding of Obstruction Impact of Aficamten in HCM

Professor P. Elliott (London, GB)

Access the full session

Session thumbnail

Late breaking clinical trials: LVAD, HFpEF and hypertrophic cardiomyopathy

The Event

Event poster

Heart Failure 2024

13 May 2024 14:05 CET

You may be interested in

Congress Presentation

Novel medical approach to treating obesity

18 May 2025

Congress Presentation

Discussant review - STEP-HFpEF

25 August 2023

Congress Presentation

STEP HFpEF: once-weekly semaglutide in people with HFpEF and obesity

25 August 2023

Congress Presentation

The benefits of weight loss in heart failure: is it the weight loss or the drug?

13 May 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources